Motif Neurotech is pioneering wireless minimally-invasive neuromodulation therapeutics for mental health. The company's lead product is a miniature implant in development for treatment resistant depression. Motif's implant is enabled by wireless magnetoelectric power transfer technology developed at Rice University and founded by Rice Faculty Jacob Robinson, Kaiyuan Yang, and physicians Sunil Sheth, and Sameer Sheth.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/24/24 | $18,750,000 | Series A |
Arboretum Ventures Capital Factory Divergent Capital Dolby Family Ventures Empath Ventures KdT Ventures Max Hodak PsyMed Ventures re.Mind Capital Satori Neuro TMC Innovation | undisclosed |
